Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era. [electronic resource]
Producer: 20210317Description: 21-32 p. digitalISSN:- 1097-0215
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cisplatin -- administration & dosage
- Cohort Studies
- Humans
- Incidence
- Male
- Middle Aged
- Neoplasms, Germ Cell and Embryonal -- drug therapy
- Neoplasms, Second Primary -- epidemiology
- Norway -- epidemiology
- Registries
- Risk
- Testicular Neoplasms -- drug therapy
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.